JohnVargaMD
Rheumatology • Ann Arbor, MIScleroderma & Related
John and Nancy Hughes Distinguished Professor of Rheumatology, Northwestern University Medical School
Dr. Varga is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1500 E Medical Center Dr
Ann Arbor, MI 48109Phone+1 734-936-4000
Summary
- I received my MD from New York University. Following Medicine residency at Rhode Island Hospital, trained in Rheumatology at Boston University, and then completed a basic research post-doc at the University of Pennsylvania
I moved to the Midwest in 1995, and joined the faculty at Northwestern University in 2004. I founded the Scleroderma Program and run a basic/translational research lab focusing on fibrosis and precision medicine
Education & Training
University of Pennsylvania Health SystemFellowship, Rheumatology, 1985 - 1987
Boston University Medical CenterFellowship, Rheumatology, 1983 - 1985
Rhode Island Hospital/Brown University HealthResidency, Internal Medicine, 1980 - 1983
New York University School of MedicineClass of 1980
Certifications & Licensure
MI State Medical License 2020 - 2026
IL State Medical License 1995 - 2020
PA State Medical License 1985 - 1996
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- Member Association of American Physicians
- Member AOA
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
- Join now to see all
Publications & Presentations
PubMed
- Publisher Correction: An international perspective on the future of systemic sclerosis research.David J Abraham, Carol M Black, Christopher P Denton, Jörg H W Distler, Robyn Domsic
Nature Reviews. Rheumatology. 2025-04-01 - An international perspective on the future of systemic sclerosis research.David J Abraham, Carol M Black, Christopher P Denton, Jörg H W Distler, Robyn Domsic
Nature Reviews. Rheumatology. 2025-03-01 - Genome-wide mutagenesis reported in systemic sclerosis.Carol M Artlett, John Varga
Nature Reviews. Rheumatology. 2025-03-01
Journal Articles
- Emerging Targets of Disease-Modifying Therapy for Systemic SclerosisElizabeth R Volkmann, John Varga, Nature
- Adipocyte-Specific Repression of PPAR-Gamma by NCoR Contributes to Scleroderma Skin FibrosisWarren Tourtellotte, Benjamin Korman, John Varga, BioMed Central
Other
- Overview of the clinical manifestations of systemic sclerosis (scleroderma) in adultsVarga J
http://www.uptodate.com/contents/overview-of-the-clinical-manifestations-of-systemic-sclerosis-scler
UpToDate, Wolters Kluwer Health - 2012-11-19 - Diagnosis and differential diagnosis of systemic sclerosis (scleroderma) in adultsVarga J
http://www.uptodate.com/contents/diagnosis-and-differential-diagnosis-of-systemic-sclerosis-sclerode
UpToDate, Wolters Kluwer Health - 2012-11-19 - Risk factors for and possible causes of systemic sclerosis (scleroderma)Varga J
http://www.uptodate.com/contents/risk-factors-for-and-possible-causes-of-systemic-sclerosis-sclerode
UpToDate, Wolters Kluwer Health - 2012-04-17 - Join now to see all
Press Mentions
Antibody Targeting CD38 Enzyme Shows Positive Impact in Treating Systemic SclerosisSeptember 6th, 2024- Could Getting Rid of Old Cells Turn Back the Clock on Aging?January 2nd, 2023
- How the Western Diet and Gut Bacteria Can Lead to Scarring, Vessel Damage in SclerodermaAugust 23rd, 2022
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
